Evidence map›Paper›PMID 16997863›Full record

ArticleBiophysical journal2006

The lipid-associated 3D structure of SPA, a broad-spectrum neuropeptide antagonist with anticancer properties.

David A Keire, Mohanraja Kumar, Weidong Hu, James Sinnett-Smith, Enrique Rozengurt

Open access · bronzeAbstract read
In one paragraph

Article in Biophysical journal, 2006. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.1field-weighted citation impact, top 48% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 6 citations in OpenAlex.

  1. MedChemComm · 2017
    Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

David A KeireCURE Digestive Diseases Research Center, VA Greater Los Angeles Healthcare System, Los Angeles, CA 90073, USA. dkeire@ucla.edu
Mohanraja Kumar
Weidong Hu
James Sinnett-Smith
Enrique Rozengurt
University of California, Los Angeles · USVA Greater Los Angeles Healthcare System · USBeckman Research Institute

Funding

Pilot and Feasibility ProgramP30DK041301 · NIDDK · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI ROZENGURT, JUAN ENRIQUE · 1990 to 2019
$18.0M
UCLA SPORE IN LUNG CANCERP50CA090388 · NCI · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI DUBINETT, STEVEN M. · 2001 to 2008
$13.0M
Gastrointestinal Physiology of PYY--Role of 3D StructureR01DK056805 · NIDDK · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI REEVE, JOSEPH R · 2001 to 2005
$1.6M
NCI NIH HHS 1 P50 CA90388NCI NIH HHS P50 CA090388NIDDK NIH HHS DK 41301NIDDK NIH HHS DK56805NIDDK NIH HHS P30 DK041301NIDDK NIH HHS R01 DK056805
6 · The paper itself

Abstract

[D-Arg(1), D-Trp(5,7,9), Leu(11)] substance P (SPA) belongs to a family of peptides including antagonist G and SpD that act as broad-spectrum neuropeptide antagonists at several peripheral receptors. The lipid-induced structure of these peptides may be important for the receptor interactions of these analogs. Thus we describe the tertiary structure of SPA in the presence of sodium dodecylsulfate micelles at pH 5.0, and 25 degrees C as determined from two-dimensional (1)H-NMR data recorded at 500 MHz. The resulting three-dimensional structure can be generally described as two type IV nonstandard turns around Arg(1)*, Pro(2), Lys(3), and Pro(4) and Gln(6), Trp(7)*, Phe(8), and Trp(9)* residues, respectively, inserted into the interfacial region of the micelles (the asterisks denote D-form amino acid). These turns juxtapose the N- and C-termini of SPA and may form the basis of this peptide's unique ability to inhibit peptide receptor interactions at multiple receptor types.

Indexed as

Models, MolecularAntineoplastic AgentsCircular DichroismMembranes, ArtificialMicellesNeuropeptidesNuclear Magnetic Resonance, BiomolecularProtein Structure, TertiarySodium Dodecyl SulfateSolutionsSpectrometry, FluorescenceSubstance PWaterAntineoplastic AgentsMembranes, ArtificialMicellesNeuropeptidesSodium Dodecyl SulfateSolutionsSubstance Psubstance P, Arg(1)-Trp(5,7,9)-Leu(11)-Water

Identifiers

PMID16997863
PMCPMC1779918
OpenAlexW2049247412

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.